PTC Therapeutics shares are trading higher after Morgan Stanley upgraded the stock from Underweight to Equal-Weight and raised its price target from $28 to $30.

PTC Therapeutics, Inc. -0.55%

PTC Therapeutics, Inc.

PTCT

32.63

-0.55%

PTC Therapeutics shares are trading higher after Morgan Stanley upgraded the stock from Underweight to Equal-Weight and raised its price target from $28 to $30.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via